Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Tyson

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer|December 1, 1993
Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasoneM G Kris, L Baltzer, K M Pisters, et al.
Journal of the National Cancer Institute|January 4, 1989
Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer|August 15, 1992
Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesisM G Kris, L B Tyson, R A Clark, et al.
Seminars in Oncology Nursing|May 1, 1989
Antiemetic therapy: management of chemotherapy-induced nausea and vomitingR A Clark, L B Tyson, R J Gralla, et al.
The Medical Clinics of North America|March 1, 1987
The management of chemotherapy-induced nausea and vomitingR J Gralla, L B Tyson, M G Kris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Methodology in anti-emetic trialsR J Gralla, R A Clark, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapyM G Kris, R J Gralla, R A Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer|February 1, 1994
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatinL Baltzer, M G Kris, L B Tyson, et al.
Cancer|December 1, 1987
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trialM G Kris, R J Gralla, R A Clark, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer|December 1, 1993
Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasoneM G Kris, L Baltzer, K M Pisters, et al.
Journal of the National Cancer Institute|January 4, 1989
Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer|August 15, 1992
Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesisM G Kris, L B Tyson, R A Clark, et al.
Seminars in Oncology Nursing|May 1, 1989
Antiemetic therapy: management of chemotherapy-induced nausea and vomitingR A Clark, L B Tyson, R J Gralla, et al.
The Medical Clinics of North America|March 1, 1987
The management of chemotherapy-induced nausea and vomitingR J Gralla, L B Tyson, M G Kris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Methodology in anti-emetic trialsR J Gralla, R A Clark, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapyM G Kris, R J Gralla, R A Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer|February 1, 1994
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatinL Baltzer, M G Kris, L B Tyson, et al.
Cancer|December 1, 1987
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trialM G Kris, R J Gralla, R A Clark, et al.
Pageof 3